Pursuant to Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements), Hester Biosciences has informed that the company is in receipt of intimation from the shareholder regarding loss of share certificate(s), as per the details are enclosed.
The above information is a part of company’s filings submitted to BSE.